Zydus gets emergency use approval by the DCGI to treat moderate infections in adults

The DCGI has given approval to the Virafin drug by the Zydus to be used in an emergency to treat moderately affected adults. Reports have suggested that 91.15% of people tested negative within seven days of its usage. The miracle drug comes amidst a huge shortage of medicines in the country. The phase three trials will also bring in more life-saving drugs which could be helpful in bringing down the morbidity rate in the country. India stands second in the world in terms of the worst case of infections from all across the world. Watch the video to know more.